Filter by: patients
Home > Community Treatment Reports and Side Effects > Cilostazol Treatment Report
What is Cilostazol?

Cilostazol is an antiplatelet drug that is used for the symptomatic management of peripheral vascular disease, primarily intermittent claudication.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Other 2 2 Efficacy_moderate Efficacy_slight
Pain in legs 1 0
Increase effect of another treatment 1 1 Efficacy_none
Raynaud's Disease 1 0
Cramps in legs 1 1 Efficacy_moderate

See all 2 patients currently taking Cilostazol

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 1
Moderate
 0
Mild
 0
None
 3

Reported Dosages

  50 mg daily 200 mg daily
  2 Number of Patients: 2 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Cilostazol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 33%
Side effects too severe 1   Side effects too severe: 33%
Course of treatment ended 1   Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Cilostazol

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Cilostazol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Cilostazol

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Cilostazol

Always
 3 75%
Usually
 1 25%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Cilostazol

Very
 0 0%
Somewhat
 1 25%
A little
 1 25%
Not at all
 2 50%

Cost

Paid out of pocket

Cost of Cilostazol

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 3 100%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.